EU Biosimilar Filings, Opinions & Approvals

New biosimilar product filings for review by the European Medicines Agency’s human medicines committee (the CHMP), CHMP opinions, withdrawals of applications and decisions on biosimilar marketing authorizations by the European Commission. Updated monthly.